News for Pfizer Limited (PFIZER.NS)

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for weight loss and anti-diabetic medicine, as it pivots away from the US generics market

Pfizer's BRAFTOVI ® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Beam Therapeutics to present updated BEAM-101 trial data

Indian markets declined on Monday, with selling pressure in banks and auto stocks. Subdued trading volumes and FII outflows weighed on sentiment. A strengthening dollar and high valuations also impacted the market. IT and pharma sectors outperformed.

In the Nifty 50 index, 11 stocks ended in the green, while 39 stocks closed in the red in today's trade.

Indian markets tumbled on Friday, mirroring global anxieties over the US Federal Reserve's projected slower rate cuts. Heavy selling in financial and IT stocks pushed the Sensex down 1.5% and Nifty 1.52%, as foreign funds flowed out. European markets also declined, while US stocks rebounded slightly after a positive inflation report.

Pfizer India expanding R&D, manufacturing, and adult vaccination initiatives, showcasing commitment to the country's healthcare sector.

India's largest institutional investor, LIC, has reduced its stake in over 100 NSE-listed companies, reaching a record low ownership of 3.59%. This move comes amidst a volatile market where FIIs have withdrawn significantly, impacting the Nifty. Despite this, experts believe India's valuation remains reasonable, with earnings growth expected to continue.

Indian investors focus on domestic markets due to strong growth, overlooking global opportunities. Restrictions and paperwork also deter foreign investments. Global diversification offers high-quality businesses and growth in sectors absent in India, like AI and gaming.

The northward movement in the rally follows the announcement of a whopping 350 per cent dividend, or Rs 35 per share, for FY24

Indian equity indices ended Monday with mixed results. Gain in energy and metals stocks balanced by profit booking in financials left the Nifty 50 index slightly up and Sensex nearly unchanged. Analysts forecasted range-bound movement, noting crucial support and resistance levels.

Indian benchmark indices surged over 1.5% on Friday, driven by positive global outlooks and strong U.S. economic data. The NSE Nifty 50 closed 1.65% higher at 24,541.15, and S&P BSE Sensex rose by 1.68% to 80,436.84.

Stocks to watch today, July 30, 2024: GIFT Nifty indicates a lacklustre start for the benchmark equity indices on Tuesday. Here are buzzing stocks to watch during today's trading session

Stocks to watch today, July 29, 2024: GIFT Nifty indicates a positive start for the benchmark equity indices on Monday. Here are buzzing stocks to watch during today's trading session

All you need to know before the market opens today: GIFT Nifty futures were quoting atop 25,000-mark, hinting at over 100 points gap-up. Nikkei rallied nearly 3 per cent, while Kospi gained over 1 per

Domestic headline indices Nifty 50 and Sensex finished at record closing highs yet again boosted by strong domestic inflows as well as a climb in global equities. For the last few days, Nifty has been moving sideways on an intraday basis, but eventually it has moved up above 23,500. MACD showed bullish trade on the counters of ABB India, Hindustan Aeronautics, Cochin Shipyards, BEML, Godfrey Phillips India, and Cummins India.

The Nifty Pharma index closed 0.65 per cent down at 18404.6.

The Nifty Pharma index closed 0.12 per cent down at 19185.15.

The Nifty Pharma index closed 1.11 per cent up at 19207.9.